Europe must learn from US biotech success
Europe must change its attitude towards entrepreneurs before its biotechnology industry is successful as that in the USA, according to Belgian industrialist Eric Tambuyzer. Mr Tambuyzer, European board member for the US company Genzyme, told BioMedNet News that while in Europe entrepreneurial failure attracts ridicule and a lack of trust, 'in the US when you make a company and you fail, you start a new company and you learn from your experience.' Mr Tambuyzer, also Chairman of EuropaBio (European association for bioIndustries), said it is this attitude to entrepreneurship, not money or expertise, which distinguishes the US biotech industry from that in Europe. Success in biotechnology is about 'picking yourself up, dusting yourself down and starting all over again,' he explained.